nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Nervous system disorder—Cisplatin—bone cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Thrombocytopenia—Cisplatin—bone cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Blood creatinine increased—Epirubicin—bone cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Tachycardia—Cisplatin—bone cancer	0.00247	0.00247	CcSEcCtD
Meropenem—Skin disorder—Cisplatin—bone cancer	0.00246	0.00246	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00245	0.00245	CcSEcCtD
Meropenem—Hyperhidrosis—Cisplatin—bone cancer	0.00245	0.00245	CcSEcCtD
Meropenem—Asthma—Methotrexate—bone cancer	0.00244	0.00244	CcSEcCtD
Meropenem—Eosinophilia—Methotrexate—bone cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Anorexia—Cisplatin—bone cancer	0.00241	0.00241	CcSEcCtD
Meropenem—Hypokalaemia—Epirubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00238	0.00238	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00238	0.00238	CcSEcCtD
Meropenem—Hypotension—Cisplatin—bone cancer	0.00237	0.00237	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—bone cancer	0.0023	0.0023	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—bone cancer	0.00229	0.00229	CcSEcCtD
Meropenem—Asthma—Epirubicin—bone cancer	0.00229	0.00229	CcSEcCtD
Meropenem—Dysuria—Methotrexate—bone cancer	0.00228	0.00228	CcSEcCtD
Meropenem—Neutropenia—Methotrexate—bone cancer	0.00228	0.00228	CcSEcCtD
Meropenem—Paraesthesia—Cisplatin—bone cancer	0.00227	0.00227	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—bone cancer	0.00226	0.00226	CcSEcCtD
Meropenem—Dyspnoea—Cisplatin—bone cancer	0.00226	0.00226	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Decreased appetite—Cisplatin—bone cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Pneumonia—Methotrexate—bone cancer	0.00219	0.00219	CcSEcCtD
Meropenem—Gastrointestinal disorder—Cisplatin—bone cancer	0.00219	0.00219	CcSEcCtD
Meropenem—Infestation NOS—Methotrexate—bone cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Infestation—Methotrexate—bone cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Pain—Cisplatin—bone cancer	0.00216	0.00216	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00216	0.00216	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00216	0.00216	CcSEcCtD
Meropenem—Renal failure—Methotrexate—bone cancer	0.00214	0.00214	CcSEcCtD
Meropenem—Dysuria—Epirubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—bone cancer	0.00214	0.00214	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—bone cancer	0.00213	0.00213	CcSEcCtD
Meropenem—Asthma—Doxorubicin—bone cancer	0.00212	0.00212	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—bone cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Sweating—Methotrexate—bone cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Feeling abnormal—Cisplatin—bone cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—bone cancer	0.00206	0.00206	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—bone cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—bone cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Infestation—Epirubicin—bone cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—bone cancer	0.00203	0.00203	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00202	0.00202	CcSEcCtD
Meropenem—Renal failure—Epirubicin—bone cancer	0.002	0.002	CcSEcCtD
Meropenem—Body temperature increased—Cisplatin—bone cancer	0.002	0.002	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—bone cancer	0.002	0.002	CcSEcCtD
Meropenem—Jaundice—Epirubicin—bone cancer	0.00199	0.00199	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—bone cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—bone cancer	0.00197	0.00197	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—bone cancer	0.00196	0.00196	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—bone cancer	0.00196	0.00196	CcSEcCtD
Meropenem—Sweating—Epirubicin—bone cancer	0.00195	0.00195	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—bone cancer	0.00194	0.00194	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—bone cancer	0.00193	0.00193	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—bone cancer	0.0019	0.0019	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Meropenem—Infestation—Doxorubicin—bone cancer	0.00189	0.00189	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Meropenem—Hypersensitivity—Cisplatin—bone cancer	0.00186	0.00186	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—bone cancer	0.00186	0.00186	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—bone cancer	0.00185	0.00185	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—bone cancer	0.00184	0.00184	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—bone cancer	0.00183	0.00183	CcSEcCtD
Meropenem—Asthenia—Cisplatin—bone cancer	0.00182	0.00182	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—bone cancer	0.00182	0.00182	CcSEcCtD
Meropenem—Sweating—Doxorubicin—bone cancer	0.00181	0.00181	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—bone cancer	0.0018	0.0018	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—bone cancer	0.00177	0.00177	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—bone cancer	0.00176	0.00176	CcSEcCtD
Meropenem—Chills—Methotrexate—bone cancer	0.00175	0.00175	CcSEcCtD
Meropenem—Diarrhoea—Cisplatin—bone cancer	0.00173	0.00173	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—bone cancer	0.00172	0.00172	CcSEcCtD
Meropenem—Erythema—Methotrexate—bone cancer	0.0017	0.0017	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—bone cancer	0.0017	0.0017	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—bone cancer	0.00169	0.00169	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—bone cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—bone cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Meropenem—Back pain—Methotrexate—bone cancer	0.00165	0.00165	CcSEcCtD
Meropenem—Chills—Epirubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Meropenem—Vomiting—Cisplatin—bone cancer	0.00161	0.00161	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—bone cancer	0.0016	0.0016	CcSEcCtD
Meropenem—Rash—Cisplatin—bone cancer	0.0016	0.0016	CcSEcCtD
Meropenem—Dermatitis—Cisplatin—bone cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Erythema—Epirubicin—bone cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Anaemia—Methotrexate—bone cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Flatulence—Epirubicin—bone cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Tension—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—bone cancer	0.00156	0.00156	CcSEcCtD
Meropenem—Nervousness—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Meropenem—Back pain—Epirubicin—bone cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Malaise—Methotrexate—bone cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—bone cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—bone cancer	0.00152	0.00152	CcSEcCtD
Meropenem—Chills—Doxorubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Meropenem—Nausea—Cisplatin—bone cancer	0.0015	0.0015	CcSEcCtD
Meropenem—Cough—Methotrexate—bone cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Erythema—Doxorubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Meropenem—Anaemia—Epirubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Meropenem—Agitation—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Chest pain—Methotrexate—bone cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Tension—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Malaise—Epirubicin—bone cancer	0.00144	0.00144	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Syncope—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Back pain—Doxorubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Confusional state—Methotrexate—bone cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—bone cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Cough—Epirubicin—bone cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—bone cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Infection—Methotrexate—bone cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Hypertension—Epirubicin—bone cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—bone cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—bone cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Chest pain—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Agitation—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Meropenem—Anxiety—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—bone cancer	0.00135	0.00135	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Malaise—Doxorubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Meropenem—Anorexia—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Syncope—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Confusional state—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Oedema—Epirubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Hypotension—Methotrexate—bone cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Infection—Epirubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Cough—Doxorubicin—bone cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Shock—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Insomnia—Methotrexate—bone cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Anorexia—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—bone cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Somnolence—Methotrexate—bone cancer	0.00123	0.00123	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—bone cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Hypotension—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Oedema—Doxorubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Infection—Doxorubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Meropenem—Pain—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Meropenem—Shock—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Insomnia—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Somnolence—Epirubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Meropenem—Pain—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Constipation—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Urticaria—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Meropenem—Urticaria—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Pain—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Constipation—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—bone cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Asthenia—Methotrexate—bone cancer	0.000997	0.000997	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—bone cancer	0.000991	0.000991	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—bone cancer	0.000984	0.000984	CcSEcCtD
Meropenem—Pruritus—Methotrexate—bone cancer	0.000983	0.000983	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—bone cancer	0.000958	0.000958	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—bone cancer	0.000956	0.000956	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—bone cancer	0.000951	0.000951	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—bone cancer	0.000951	0.000951	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—bone cancer	0.00095	0.00095	CcSEcCtD
Meropenem—Asthenia—Epirubicin—bone cancer	0.000933	0.000933	CcSEcCtD
Meropenem—Pruritus—Epirubicin—bone cancer	0.00092	0.00092	CcSEcCtD
Meropenem—Dizziness—Methotrexate—bone cancer	0.000919	0.000919	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—bone cancer	0.000889	0.000889	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—bone cancer	0.000886	0.000886	CcSEcCtD
Meropenem—Vomiting—Methotrexate—bone cancer	0.000883	0.000883	CcSEcCtD
Meropenem—Rash—Methotrexate—bone cancer	0.000876	0.000876	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—bone cancer	0.000875	0.000875	CcSEcCtD
Meropenem—Headache—Methotrexate—bone cancer	0.00087	0.00087	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—bone cancer	0.000863	0.000863	CcSEcCtD
Meropenem—Dizziness—Epirubicin—bone cancer	0.00086	0.00086	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—bone cancer	0.000851	0.000851	CcSEcCtD
Meropenem—Vomiting—Epirubicin—bone cancer	0.000827	0.000827	CcSEcCtD
Meropenem—Nausea—Methotrexate—bone cancer	0.000825	0.000825	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—bone cancer	0.000823	0.000823	CcSEcCtD
Meropenem—Rash—Epirubicin—bone cancer	0.00082	0.00082	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—bone cancer	0.000819	0.000819	CcSEcCtD
Meropenem—Headache—Epirubicin—bone cancer	0.000814	0.000814	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—bone cancer	0.000795	0.000795	CcSEcCtD
Meropenem—Nausea—Epirubicin—bone cancer	0.000772	0.000772	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—bone cancer	0.000765	0.000765	CcSEcCtD
Meropenem—Rash—Doxorubicin—bone cancer	0.000758	0.000758	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—bone cancer	0.000758	0.000758	CcSEcCtD
Meropenem—Headache—Doxorubicin—bone cancer	0.000753	0.000753	CcSEcCtD
Meropenem—Nausea—Doxorubicin—bone cancer	0.000714	0.000714	CcSEcCtD
